Please contact us at least 3 weeks before the submission deadline.
This enables us to provide qualitative advice and support.
The open calls are sorted by submission deadline.
VLAIO – International ITEA-call 2025 and match making event
ITEA is an industry-driven European ecosystem for collaborative R&D projects on software-intensive systems. ITEA projects cover all topics related to software innovation, including:
- Artificial intelligence (e.g. large language models and other generative AI)
- Smart healthcare
- Cybersecurity (digital safety and security)
- Industry 4.0 and smart engineering, including simulation tools, digital twins, robotics and IoT
- Sustainability, including smart mobility and smart cities
Participating countries include Austria, Belgium (Flanders: VLAIO; Brussels: Innoviris; Wallonia: SPW), Canada, the Czech Republic, Germany, Denmark, Spain, Estonia, Finland, France, the United Kingdom, Hungary, South Korea, Lithuania, the Netherlands, Portugal, Romania, Sweden and Turkey.
Deadline: 10 November 2025 (concept); 29 May 2026 (full proposal)
KOTK – Upcoming call: Inter-local call – Advancing Clinical Research in Local Cancer Treatments
The call will officially open in December 2025. Detailed information on eligibility, guidelines, and application procedures will be published on the dedicated call website in the coming months. A webinar and Q&A session will also be organised to support prospective applicants.
EU – ERA4Health Partnership – Call PREVENT-OO ‘Understanding and Preventing Overweight and Obesity’
Focus on mechanisms of their onset and progression, neglected determinants and novel strategies for critical transitional periods in life. Applications must cover only one of the two following topics:
- Research that improves the understanding of the causes for obesity, overweight and its complications by using a mechanistic approach.
- Research that focuses on prevention and public health strategies for critical transitional periods of life.
Deadline: 21 January 2026 (pre-proposal), 11 June 2026 (full proposal)
Preliminary announcement – Trials4Health2026 Call (KCE)
Together with the partnership ‘Fostering a European Research Area for Health Research’ (ERA4Health), KCE Trials is happy to announce the “Trials4Health 2026” call will open on 6 November 2025.
This call provides funding for multi-country, comparative effectiveness or drug repurposing Investigator-Initiated Clinical Studies (IICS) in Cardiovascular, Autoimmune and Metabolic diseases. Deadline for submission will be 27 January 2026.
Fund for Cardiac Surgery – Call for research projects in medical-surgical cardiology 2026
Deadline: 31 January 2026
EU – European Partnership One Health AMR – Call on new treatments to tackle AMR
The aim of this first EUP OHAMR Call, foreseen to be launched on 18 November, is to improve the treatment success rates of the patients, animals and plants affected by bacterial or fungal infections by providing new treatment options while reducing the risk of resistance in the different One Health settings.
Proposals submitted under the call need to address one of the following topics:
- Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance
- Topic 2: Develop tools and methods to improve adherence to treatment protocols
- Topic 3: Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use
Deadline: 2 February 2026 (pre-proposal)
King Baudouin Foundation – GENeHOPE – research on genetic diseases
Financial contribution to joint research into genetic diseases between a research team from Belgium and a team from the Institut Imagine France.
Budget: 200.000 euro
Deadline: 03 February 2026
Leukemia Research Foundation
The application portal for the 2025 funding cycle is now open! Grants of up to $150K over a two-year period are available to early career investigators — researchers within seven years after their first independent faculty-level position.
Making progress in treating and ultimately curing leukemia and MDS requires advances across the research continuum – from understanding the fundamental biology of cancer cells to preventing relapse after treatment. All projects that help move the field forward toward a better understanding of the diseases, improved symptom management and more effective treatment will be considered.
Budget: $150.000
Deadline: 6 February 2026 (LOI); 13 April 2026 (full proposal)
EU – EP PerMed Joint Transnational Call (JTC) 2026 – Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
Deadline: 10 February 2026 (pre-proposal), 9 June 2026 (full proposal)
EU – ERDERA – Joint Transnational Call 2026
On 10 December 2025, ERDERA will launch its 2026 Joint Transnational Call, “Resolving unsolved cases in rare genetic and non‑genetic diseases through variant validation and new technological approaches”.
The call will welcome proposals focused on providing diagnostic clarity in unsolved rare genetic and non‑genetic diseases.
This call’s pre‑announcement is available below, and it describes the forthcoming opportunity for multinational research teams to apply and will be updated with the full call when it launches.
Involving patient organisations from the very start is highly desirable. Should you need guidance about patient involvement in research, have a look at this guide.
Deadline: 12 February 2026 (pre-proposal); 8 July 2026 (full proposal)
This list is non-exhaustive